Identification of pathogenic variants in cancer genes using base editing screens

Millions of nucleotide variants have been identified through cancer genome sequencing and it is clinically important to identify the pathogenic variants among them. By introducing base substitutions at guide RNA target regions in the genome, CRISPR-Cas9-based base editors have provided the possibility for evaluating a large number of variants in their genomic context.